Suppr超能文献

靶向聚乙二醇化壳聚糖纳米复合物递送丁酸钠治疗前列腺癌的体外研究。

Targeted PEGylated Chitosan Nano-complex for Delivery of Sodium Butyrate to Prostate Cancer: An In Vitro Study.

机构信息

Department of Genetics, Faculty of Advanced Sciences and Technology, Tehran Medical Science, 68106Islamic Azad University, Tehran, Iran.

Department of Biology, Division of Cellular and Molecular Biology, Nourdanesh University of Meymeh, Meymeh, Isfahan, Iran.

出版信息

Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231159223. doi: 10.1177/15330338231159223.

Abstract

Cancer remains a challenging issue against human health throughout the world; As a result, introducing novel approaches would be beneficial for cancer treatment. In this research, sodium butyrate (Sb) is one of the effective anti-cancer therapeutics (also a potent survival factor for normal cells) that was used for prostate cancer suppression in the platform of modified chitosan (CS) nano-complex (polyethylene glycol (PEG)-folic acid (FA)-Sb-CS). Different analytical devices including Fourier transform infrared, dynamic light scattering, high-performance liquid chromatography, scanning electron microscopy, and transmission electron microscopy were applied for the characterization of synthetics. On the other hand, biomedical tests including cell viability assay, molecular and functional assay of apoptosis/autophagy pathways, and cell cycle arrest analysis were potentially implemented on human PC3 (folate receptor-negative prostate cancer) and DU145 (folate receptor-positive prostate cancer) and HFF-1 normal cell lines. The quality of the syntheses was effectively verified, and the size range from 140 to 170 nm was determined for the PEG-CS-FA-Sb sample. Also, 75  ±  5% of drug entrapment efficiency with controlled drug release manner (Sb release of 54.21% and 74.04% for pHs 7.4 and 5.0) were determined for nano-complex. Based on MTT results, PEG-CS-FA-Sb has indicated 72.07% and 33.53% cell viability after 24 h of treatment with 9 mM on PC3 and DU145 cell lines, respectively, which is desirable anti-cancer performance. The apoptotic and autophagy genes overexpression was 15-fold (caspase9), 2.5-fold (BAX), 11-fold (ATG5), 2-fold (BECLIN1), and 3-fold (mTORC1) genes in DU145 cancer cells. More than 50% of cell cycle arrest and 45.05% of apoptosis were obtained for DU145 cancer cells after treatment with nano-complex. Hence, the synthesized Sb-loaded nano-complex could specifically suppress prostate cancer cell growth and induce apoptosis and autophagy in the molecular and cellular phases.

摘要

癌症仍然是全世界人类健康面临的一个具有挑战性的问题;因此,引入新的方法将有益于癌症的治疗。在这项研究中,丁酸钠(Sb)是一种有效的抗癌治疗药物(也是正常细胞的有效生存因子),它被用于修饰壳聚糖(CS)纳米复合物(聚乙二醇(PEG)-叶酸(FA)-Sb-CS)中的前列腺癌抑制。 包括傅里叶变换红外光谱、动态光散射、高效液相色谱、扫描电子显微镜和透射电子显微镜在内的不同分析设备被用于合成物的表征。另一方面,包括细胞活力测定、细胞凋亡/自噬途径的分子和功能测定以及细胞周期阻滞分析在内的生物医学测试在人前列腺癌细胞系 PC3(叶酸受体阴性前列腺癌)和 DU145(叶酸受体阳性前列腺癌)和 HFF-1 正常细胞系上进行了潜在的实施。 合成物的质量得到了有效验证,PEG-CS-FA-Sb 样品的粒径范围为 140-170nm。此外,纳米复合物的药物包封效率为 75±5%,药物释放方式为控制释放(pH 值为 7.4 和 5.0 时 Sb 释放分别为 54.21%和 74.04%)。基于 MTT 结果,PEG-CS-FA-Sb 在处理 PC3 和 DU145 细胞系时,在 9mM 时分别显示出 24 小时后 72.07%和 33.53%的细胞活力,表现出理想的抗癌性能。凋亡和自噬基因的过表达倍数分别为 caspase9 为 15 倍、BAX 为 2.5 倍、ATG5 为 11 倍、BECLIN1 为 2 倍和 mTORC1 为 3 倍,在 DU145 癌细胞中。用纳米复合物处理 DU145 癌细胞后,细胞周期阻滞率达到 50%以上,凋亡率达到 45.05%。 因此,负载 Sb 的纳米复合物的合成物可以特异性地抑制前列腺癌细胞的生长,并在分子和细胞水平诱导细胞凋亡和自噬。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee5b/9983112/6551aa3ace8a/10.1177_15330338231159223-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验